Results 41 to 50 of about 5,257 (166)
Treatment of renal congestion by tolvaptan [PDF]
Hypertension Research, 2019 Satoshi Kinugasa +2 more
openaire +3 more sources
Tolvaptan - Vasopressin Antagonist for Hyponatremia
, 2023 The groundbreaking TEMPO 3:4 trial, which served as the basis for tolvaptan's approval, represented a revolution in the treatment of autosomal dominant polycystic kidney disease (ADPKD). Through this advancement, patient management for ADPKD has evolved from using broad strategies to stop the progression of chronic kidney disease to focusing on disease-
openaire +2 more sources
Standard Poster Abstracts for the 17th Asia Pacific Heart Rhythm Society (APHRS) Scientific Sessions
Journal of Arrhythmia, Volume 41, Issue 2, April 2025.
wiley +1 more source
Comparison of Two Doses and Dosing Regimens of Tolvaptan in Congestive Heart Failure
, 2005 Paul J. Hauptman +6 more
openalex +1 more source
Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial [PDF]
, 2014 Satoshi Suzuki +12 more
openalex +1 more source
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome
, 2008 W.H. Wilson Tang
openalex +2 more sources
BNP Level Predicts Clinical Efficacy of Tolvaptan in Patients with Heart Failure [PDF]
, 2014 Seiichirou Yoshimura +9 more
openalex +1 more source